文献速递妇科

动态对比增强超声可提高子宫内膜癌分期的诊断效能

Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging.
PubMed 文献 · Ultrasound Obstet Gynecol · 2020-01-01

前瞻性研究纳入93例子宫内膜癌患者,行二维经阴道超声/能量多普勒(2D-TVU/PD)联合动态对比增强超声(DCE-US),与279例仅用2D-TVU/PD的对照队列按FIGO分期和分级3:1匹配。联合DCE-US诊断深肌层浸润和宫颈间质受累的敏感度高于单独2D-TVU/PD,高危癌特异度更高,敏感度无差异。

要点

  • 联合DCE-US诊断深肌层浸润敏感度0.74 vs 0.62(P=0.036),特异度无显著差异。
  • 联合DCE-US诊断宫颈间质受累敏感度0.75 vs 0.51(P<0.001),特异度无显著差异。
  • 联合DCE-US检测高危癌特异度0.94 vs 0.85(P=0.024),敏感度0.73 vs 0.71无差异。

核心结论

  • 与单独2D-TVU/PD相比,联合DCE-US可显著提高子宫内膜癌深肌层浸润和宫颈间质受累的检出,且不增加假阳性率。
  • 联合DCE-US主要通过提高特异度改善高危疾病的正确分类,可能减少近10%的不必要扩大手术。
  • DCE-US半定量参数及「局灶性」充盈、「先于」肌层充盈、「局灶性」廓清模式均与更晚期疾病相关。

研究设计与样本

  • 前瞻性研究,纳入101例活检确诊子宫内膜癌的连续女性,在Karolinska大学医院(三级转诊中心)由专家行超声检查。
  • 所有同意女性接受DCE-US(静脉团注1.5-2.5 mL SonoVue造影剂)及常规2D-TVU/PD检查。
  • 研究队列与对照队列按FIGO分期和分级3:1匹配,对照队列为在本中心按国际子宫内膜肿瘤分析方案仅用2D-TVU/PD检查的子宫内膜癌女性。
  • 以子宫切除术后病理评估为金标准。
  • 排除后研究队列93例,匹配对照队列279例。

主要发现

  • 两队列FIGO IA期、1-2级子宫内膜癌患病率均为52%。
  • 研究队列联合DCE-US诊断深肌层浸润敏感度0.74 vs 对照队列单独2D-TVU/PD 0.62(P=0.036),特异度0.87 vs 0.85无显著差异。
  • 研究队列联合DCE-US诊断宫颈间质受累敏感度0.75 vs 对照队列单独2D-TVU/PD 0.51(P<0.001),特异度0.96 vs 0.95无显著差异。
  • 研究队列联合DCE-US检测高危癌特异度0.94 vs 对照队列单独2D-TVU/PD 0.85(P=0.024),敏感度0.73 vs 0.71无差异。
  • 主观评估DCE-US视频片段,高危癌和FIGO分期≥IB以「局灶性」充盈、「先于」肌层充盈和「局灶性」廓清模式为特征;所有半定量DCE-US参数显著预测FIGO分期≥IB,但不显著预测高危癌(尽管有明确趋势)。

关键数值与推荐

  • 高危癌定义:FIGO分期≥IB和/或3级子宫内膜样和/或非子宫内膜样组织学。
  • 深肌层浸润敏感度:联合DCE-US 0.74 vs 单独2D-TVU/PD 0.62(P=0.036)。
  • 宫颈间质受累敏感度:联合DCE-US 0.75 vs 单独2D-TVU/PD 0.51(P<0.001)。
  • 高危癌特异度:联合DCE-US 0.94 vs 单独2D-TVU/PD 0.85(P=0.024)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To compare the sensitivity and specificity of conventional two-dimensional transvaginal ultrasound/power Doppler (2D-TVU/PD) alone and 2D-TVU/PD combined with dynamic contrast-enhanced ultrasound (DCE-US) in diagnosing deep myometrial invasion (MI) and cervical stromal involvement (CSI) in women with endometrial cancer (EC), and to assess the association of DCE-US semiquantitative and qualitative variables with International Federation of Gynecology and Obstetrics (FIGO) Stage ≥ IB and 'high-risk' cancer. METHODS: This was a prospective study of 101 consecutive women with biopsy-confirmed EC, undergoing expert ultrasound examination at Karolinska University Hospital, a tertiary referral center. All consenting women underwent DCE-US using a 1.5-2.5-mL intravenous bolus of SonoVue contrast agent, as well as conventional 2D-TVU/PD examination. DCE-US videoclips were analyzed with regard to filling (global or focal), wash-in (prior, simultaneous or after) and wash-out (global or focal) patterns of the contrast agent in the tumor compared with the surrounding tissue, as well as semiquantitative DCE-US parameters (wash-in slope, time-to-peak, peak intensity and area under the time-intensity curve (TIC)) obtained from a TIC. The study cohort was compared with a control cohort of women with EC examined at our center according to the International Endometrial Tumor Analysis protocol using 2D-TVU/PD only, matched at a ratio of 3:1 for FIGO stage and grade. The sensitivity and specificity of 2D-TVU/PD alone in the control cohort and in combination with DCE-US in the study cohort in the diagnosis of deep MI, CSI and high-risk cancer (defined as FIGO Stage ≥ IB and/or Grade 3 endometrioid and/or non-endometrioid histology) were compared, using pathological evaluation after hysterectomy as the 'gold standard'. RESULTS: After exclusions, 93 women were included in the study cohort and were matched to 279 women in the control cohort. The prevalence of FIGO Stage IA, Grade 1-2 EC was 52% in both cohorts. The sensitivity of 2D-TVU/PD with DCE-US in the study cohort was higher than that of 2D-TVU/PD alone in the control cohort in diagnosing both deep MI (0.74 vs 0.62; P = 0.036) and CSI (0.75 vs 0.51; P < 0.001), whereas the specificity was not significantly different (0.87 vs 0.85 and 0.96 vs 0.95, respectively). Compared with 2D-TVU/PD alone, the specificity of 2D-TVU/PD with DCE-US was higher in detecting high-risk cancer (0.94 vs 0.85; P = 0.024) but the sensitivity did not differ (0.73 vs 0.71). High-risk cancer and FIGO Stage ≥ IB were characterized by a 'focal' filling pattern, with a 'prior' wash-in pattern and a 'focal' wash-out pattern on subjective assessment of DCE-US videoclips. All semiquantitative DCE-US parameters were significantly predictive of FIGO Stage ≥ IB but not of high-risk cancer, despite a clear trend. CONCLUSIONS: Compared with 2D-TVU/PD alone, combining 2D-TVU/PD with DCE-US can significantly improve the detection of deep MI and CSI in women with EC, without increasing the false-positive rate. It can also improve the correct classification of high-risk disease, mainly by increasing specificity, thereby possibly reducing the number of unnecessarily extensive surgeries by almost 10%. Semiquantitative DCE-US parameters, as well as a 'focal' filling pattern, endometrial wash-in prior to the myometrium and a 'focal' wash-out pattern, are all associated with more advanced disease. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Green RW, Epstein E. Dynamic contrast-enhanced ultrasound improves diagnostic performance in endometrial cancer staging. Ultrasound Obstet Gynecol. 2020. PMID: 31647145. doi:10.1002/uog.21885

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。